BioSpace News Archive

AVROBIO, Inc. today reported new interim data, including on new visual motor integration, motor coordination and visual perception measures, from a collaborator-sponsored, ongoing Phase 1/2 gene therapy clinical triali of AVR-RD-04.

GRAIL, LLC, a healthcare company whose mission is to detect cancer early when it can be cured, and Intermountain Healthcare announced that Galleri®, GRAIL’s groundbreaking multi-cancer early detection blood test, will be offered as a complement to existing single cancer screenings to help advance the delivery of cancer care through early detection.

Medical device company Linear Health Sciences has received U.S. FDA clearance and Health Canada approval of its Orchid SRV™ , a tension-activated breakaway safety release valve designed to reduce the risk of IV catheter failure and replacement in hospitals.

Forge Biologics, a gene therapy-focused contract development and manufacturing organization, announced today the formation of an independent board of preeminent experts, a Scientific and Manufacturing Advisory Board (SMAB), to advise the Company on its gene therapy manufacturing offerings and therapeutics pipeline development.

Moderna, Inc. today announced new research findings as part of the Company’s fifth annual Science and Technology Day. Moderna continues to highlight investments in the expansion of the utility of the mRNA platform, characterization of the Company’s vaccines, biodistribution of vaccines, and using clinical data to predict vaccine dosing.

The University of Nebraska Medical Center (UNMC) and ANANDA Scientific Inc announce a collaboration in a new clinical trial investigating treatment for adults with Post-Traumatic Stress Disorder (PTSD).

Arbutus Biopharma Corporation announced that William Collier, Arbutus’ President and Chief Executive Officer, will present at the H.C. Wainwright Global Investment Conference on Tuesday, May 24, 2022, at 11:30 am ET in Miami, FL.

Xilio Therapeutics, Inc. announced that Stacey Davis has been appointed as chief business officer to further the company’s corporate and business development strategy that will be central to its next stage of growth.

Avalo Therapeutics, Inc. (Nasdaq: AVTX) announced today that Garry A. Neil, M.D., President and Chief Executive Officer, will present virtually at the H.C. Wainwright Global Life Sciences Conference being held May 23-26, 2022.

BridgeBio Pharma, Inc. announced that members of the management team will participate in the following upcoming investor conferences: